Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol
dc.contributor.author | Trauth, Janina | |
dc.contributor.author | Schuler, Rahel | |
dc.contributor.author | Waitz, Markus | |
dc.contributor.author | Ehrhardt, Harald | |
dc.contributor.author | Fritzenwanker, Moritz | |
dc.contributor.author | Herold, Susanne | |
dc.date.accessioned | 2025-03-19T14:06:48Z | |
dc.date.available | 2025-03-19T14:06:48Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia. | en |
dc.identifier.uri | https://jlupub.ub.uni-giessen.de/handle/jlupub/20340 | |
dc.identifier.uri | https://doi.org/10.22029/jlupub-19691 | |
dc.language.iso | en | |
dc.rights | Namensnennung 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject.ddc | ddc:610 | |
dc.title | Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol | |
dc.type | article | |
local.affiliation | FB 11 - Medizin | |
local.source.journaltitle | Infection | |
local.source.uri | https://doi.org/10.1007/s15010-024-02404-9 |
Dateien
Originalbündel
1 - 1 von 1
Lade...
- Name:
- 10.1007_s15010-024-02404-9.pdf
- Größe:
- 816.31 KB
- Format:
- Adobe Portable Document Format